11/19
08:20 am
ltrn
Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients [Yahoo! Finance]
Low
Report
Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients [Yahoo! Finance]
11/19
08:00 am
ltrn
Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
Low
Report
Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
11/8
06:18 pm
ltrn
Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... [Yahoo! Finance]
High
Report
Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... [Yahoo! Finance]
11/7
04:05 pm
ltrn
Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
High
Report
Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
11/5
08:00 am
ltrn
Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board
Low
Report
Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board
10/31
08:00 am
ltrn
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
Medium
Report
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
10/29
06:45 pm
ltrn
Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development [Yahoo! Finance]
Medium
Report
Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development [Yahoo! Finance]
10/23
08:49 am
ltrn
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024 [Yahoo! Finance]
Low
Report
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024 [Yahoo! Finance]
10/23
08:45 am
ltrn
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
Low
Report
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
10/21
08:00 am
ltrn
Lantern Pharma to Host & Participate in Two Public Webinars During October
Medium
Report
Lantern Pharma to Host & Participate in Two Public Webinars During October
10/15
09:07 am
ltrn
Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
Medium
Report
Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
9/23
08:00 am
ltrn
Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
Medium
Report
Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
9/5
11:14 am
ltrn
BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit [Yahoo! Finance]
Low
Report
BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit [Yahoo! Finance]
8/31
02:12 pm
ltrn
Lantern Pharma Inc. (LTRN): A Penny Stock That Will Make You a Millionaire [Yahoo! Finance]
Medium
Report
Lantern Pharma Inc. (LTRN): A Penny Stock That Will Make You a Millionaire [Yahoo! Finance]